Insulin resistance a possible causal and treatable risk factor for ischemic stroke

Archives of Neurology

Volumn 67, Issue 10, 2010, Pages 1177-1178

  Hankey, Graeme J ^a,b   Feng, Tan Ze ^a,c  

^a ROYAL PERTH HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c JINAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; CHOLESTEROL; ENDOTHELIN; FIBRINOGEN; GLUCOSE; INSULIN; METFORMIN; PIOGLITAZONE; ROSIGLITAZONE;

ACUTE HEART INFARCTION; AEROBIC EXERCISE; ANTICOAGULATION; BLOOD PRESSURE MEASUREMENT; BRAIN ISCHEMIA; CARDIAC PATIENT; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY RECANALIZATION; DIABETES MELLITUS; EDITORIAL; ENERGY EXPENDITURE; ENVIRONMENTAL FACTOR; FIBRINOGEN BLOOD LEVEL; FIBRINOGEN SYNTHESIS; GLUCOSE HOMEOSTASIS; GLUCOSE TRANSPORT; GLYCEMIC CONTROL; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PHYSICIAN; PRIORITY JOURNAL; PROTEIN TRANSPORT; RISK FACTOR; RISK REDUCTION; SODIUM ABSORPTION; STROKE; SYMPATHETIC TONE; THROMBOCYTE AGGREGATION; WEIGHT REDUCTION;

HUMANS; INSULIN RESISTANCE; RISK FACTORS; STROKE;

EID: 77957938649     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneurol.2010.252     Document Type: Editorial

References (11)

1. Strong K, Mathers C, Bonita R. Preventing stroke: saving lives around the world. Lancet Neurol. 2007;6(2):182-187. (Pubitemid 46097543)
2. Feigin VL, Lawes CM, Bennett DA, Barker-Collo SL, Parag V. Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. Lancet Neurol. 2009;8(4):355-369.
3. Alberts MJ, Bhatt DL, Mas J-L, et al; REduction of Atherothrombosis for Continued Health Registry Investigators. Three-year follow-up and event rates in the international REduction of Atherothrombosis for Continued Health Registry. Eur Heart J. 2009;30(19):2318-2326.
4. Rundek T, Gardener H, Xu Q, et al. Insulin resistance and risk of ischemic stroke among nondiabetic individuals from the Northern Manhattan Study. Arch Neurol. 2010;67(10):1195-1200.
5. Bonora E, Kiechl S, Willeit J, et al. Insulin resistance as estimated by homeostasis model assessment predicts incident symptomatic cardiovascular disease in caucasian subjects from the general population: the Bruneck study. Diabetes Care. 2007;30(2):318-324.
6. Jeppesen J, Hansen TW, Rasmussen S, Ibsen H, Torp-Pedersen C, Madsbad S. Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease: a population-based study. J Am Coll Cardiol. 2007;49(21):2112-2119.
7. Bravata DM, Wells CK, Kernan WN, Concato J, Brass LM, Gulanski BI. Association between impaired insulin sensitivity and stroke. Neuroepidemiology. 2005;25(2):69-74.
8. Kernan WN, Inzucchi SE, Viscoli CM, Brass LM, Bravata DM, Horwitz RI. Insulin resistance and risk for stroke. Neurology. 2002;59(6):809-815.
9. Kernan WN, Inzucchi SE, Viscoli CM, et al. Impaired insulin sensitivity among nondiabetic patients with a recent TIA or ischemic stroke. Neurology. 2003;60(9):1447-1451.
10. Retnakaran R, Zinman B. Thiazolidinediones and clinical outcomes in type 2 diabetes. Lancet. 2009;373(9681):2088-2090.
11. Lincoff AM, Wolski K, Nicholls SJ, Nissen SE. Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials. JAMA. 2007;298(10):1180-1188.